CRABP-I Antibodies

Santa Cruz Biotechnology features a diverse variety of CRABP-I monoclonal antibodies for research applications. CRABP-I monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cellular Retinoic Acid Binding Protein I (CRABP-I) plays a crucial role in the transport and metabolism of retinoic acid, a derivative of vitamin A that is essential for numerous biological processes, including cell differentiation, growth, and embryonic development. By regulating retinoic acid availability, CRABP-I influences gene expression and cellular responses, making it a significant factor in developmental biology and cancer research. Understanding CRABP-I function is vital for elucidating its role in various physiological and pathological conditions. CRABP-I research has revealed important insights into vitamin A metabolism and its impact on cellular processes. Investigating CRABP-I expression patterns helps researchers better understand developmental pathways and potential therapeutic targets. Current studies focusing on CRABP-I continue to uncover new aspects of retinoic acid signaling pathways. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of CRABP-I's biological significance.